Waldner-Combernoux. Data monitoring and statistical analysis: C ,
Sidaction Ensemble contre le Sida and laboratories Clinical Centres (coordinators): Amiens (Pr, Financial support: Agence Nationale de Recherches sur le Sida (ANRS, Action Coordonnée n ? 7) Other support:Colì ege des Universitaires de Maladies Infectieuses et Tropicales (CMIT), (ex Association des Professeurs de Pathologie Infectieuse et Tropicale-APPIT) Bordeaux (Pr. J. Beylot, Pr. M. Dupon, Pr. Lacut, Pr. M. Le Bras, Pr. M ,
Toulon (Dr. Jaubert, Dr, Toulouse (Pr. B. Marchou, Pr. P. Massip), Tours (Pr. P. Choutet, Pr. J.M. Besnier). We thank all patients in clinical sites ,
Depressive Symptoms, Neurocognitive Impairment, and Adherence to Highly Active Antiretroviral Therapy Among HIV-Infected Persons, Psychosomatics, vol.45, issue.5, pp.45-394, 2004. ,
DOI : 10.1176/appi.psy.45.5.394
Self-Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV Infection, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.28, issue.5, pp.445-449, 2001. ,
DOI : 10.1097/00042560-200112150-00006
Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort Study, Journal of Acquired Immune Deficiency Syndromes, vol.21, issue.2, pp.114-119, 1999. ,
ABC of alcohol. Help: referral., BMJ, vol.284, issue.6314, pp.495-497, 1982. ,
DOI : 10.1136/bmj.284.6314.495
Nonadherence Among HIV-Infected Injecting Drug Users: The Impact of Social Instability, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.31, pp.31-149, 2002. ,
DOI : 10.1097/00126334-200212153-00013
Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy, Antiviral Therapy, vol.10, issue.1, pp.53-61, 2005. ,
Patient-related barriers to pain management in ambulatory AIDS patients, Pain, vol.76, issue.1, pp.9-16, 1998. ,
DOI : 10.1016/S0304-3959(98)00018-9
A comparison of pain report and adequacy of analgesic therapy in ambulatory AIDS patients with and without a history of substance abuse, Pain, vol.72, issue.1, pp.235-243, 1997. ,
DOI : 10.1016/S0304-3959(97)00039-0
Failure to maintain adherence to haart in a cohort of French HIV-positive injecting drug users, International Journal of Behavioral Medicine, vol.35, issue.2, pp.1-14, 2003. ,
DOI : 10.1207/S15327558IJBM1001_01
Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. MANIF 2000 Study Group, Journal of Epidemiology & Community Health, vol.53, issue.1, pp.4-8, 1999. ,
DOI : 10.1136/jech.53.1.4
Impact of early versus late adherence to highly active antiretroviral therapy on immuno-virological response: A 3-year followup study, Antiviral Therapy, vol.8, issue.6, pp.585-594, 2003. ,
Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users, AIDS, vol.15, issue.13, pp.15-1707, 2001. ,
DOI : 10.1097/00002030-200109070-00015
Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: A sensitization process, Journal of Neuroscience, vol.21, issue.11, pp.4074-4080, 2001. ,
Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent, Drug and Alcohol Dependence, vol.63, issue.2, pp.139-146, 2001. ,
DOI : 10.1016/S0376-8716(00)00200-3
Association of depression, CD8+ T lymphocytes, and natural killer cell activity: Implications for morbidity and mortality in human immunodeficiency virus disease, Current Psychiatry Reports, vol.15, issue.6, pp.445-450, 2003. ,
DOI : 10.1007/s11920-003-0083-4
Estimating drug consumption in opioid users: reliability and validity of a???recent use' episodes method, British Journal of Addiction, vol.33, issue.10, pp.86-1311, 1991. ,
DOI : 10.1111/j.1360-0443.1991.tb01706.x
Self-Reported Symptoms After Initiation of a Protease Inhibitor in HIV-Infected Patients and Their Impact on Adherence to HAART, HIV Clinical Trials, vol.4, issue.9, pp.38-45, 2001. ,
DOI : 10.1097/00002030-199909100-00022
Antidepressant treatment of depression in HIV-seropositive women, Journal of Clinical Psychiatry, issue.11, pp.60-741, 1999. ,
La version française de l'´ echelle CES-D Description and translation of the autoevaluation scale, Psychiatrie et Psychobiologie, vol.4, pp.163-166, 1989. ,
Development and validation of a self-completed HIV symptom index, Journal of Clinical Epidemiology, vol.54, issue.12, pp.54-77, 2001. ,
DOI : 10.1016/S0895-4356(01)00449-8
Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver, Antiviral Therapy, vol.9, issue.3, pp.407-414, 2004. ,
The validity of drug users' self-reports in a non-treatment setting: prevalence and predictors of incorrect reporting methadone treatment modalities, International Journal of Epidemiology, vol.28, issue.3, pp.514-520, 1999. ,
DOI : 10.1093/ije/28.3.514
Underestimation and undertreatment of pain in HIV disease: multicentre study, BMJ, vol.314, issue.7073, pp.314-337, 1997. ,
DOI : 10.1136/bmj.314.7073.23
Inadequate Treatment of Pain in Ambulatory HIV Patients, The Clinical Journal of Pain, vol.9, issue.4, pp.279-283, 1993. ,
DOI : 10.1097/00002508-199312000-00010
Higher Efavirenz Plasma Levels Correlate With Development of Insomnia, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.28, issue.4, pp.399-400, 2001. ,
DOI : 10.1097/00126334-200112010-00015
Pain and Aberrant Drug-Related Behaviors in Medically Ill Patients With and Without Histories of Substance Abuse, The Clinical Journal of Pain, vol.22, issue.2, pp.173-181, 2006. ,
DOI : 10.1097/01.ajp.0000161525.48245.aa
Somatic symptoms and HIV infection: Relationship to depressive symptoms and indicators of HIV disease, American Journal of Psychiatry, issue.12, pp.152-1776, 1995. ,
Insomnia in HIV Infection: A Systematic Review of Prevalence, Correlates, and Management, Psychosomatic Medicine, vol.67, issue.2, pp.260-269, 2005. ,
DOI : 10.1097/01.psy.0000151771.46127.df
High Prevalence of Insomnia in an Outpatient Population With HIV Infection, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, vol.19, issue.3, pp.260-265, 1998. ,
DOI : 10.1097/00042560-199811010-00008
Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach, Social Science & Medicine, vol.54, issue.10, pp.54-1481, 2002. ,
DOI : 10.1016/S0277-9536(01)00125-3
Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users, Journal of General Internal Medicine, vol.23, issue.4, pp.248-257, 2003. ,
DOI : 10.1046/j.1525-1497.2003.20122.x
Impact of HAART-related side effects on unsafe sexual behaviours in HIV-infected injecting drug users, AIDS, vol.18, issue.9, pp.18-1321, 2004. ,
DOI : 10.1097/00002030-200406180-00011
Symptom Prevalence, Characteristics, and Distress in AIDS Outpatients, Journal of Pain and Symptom Management, vol.18, issue.4, pp.253-262, 1999. ,
DOI : 10.1016/S0885-3924(99)00066-4
Pleasure into pain: The consequences of long-term opioid use, Addictive Behaviors, vol.29, issue.7, pp.1311-1324, 2004. ,
DOI : 10.1016/j.addbeh.2004.06.007
Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0 200 to 0, Annals of Internal Medicine, vol.350, issue.10910, pp.139-810, 2003. ,
Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users, CMAJ, issue.7, pp.169-656, 2003. ,
Antidepressant Treatment Improves Adherence to Antiretroviral Therapy Among Depressed HIV-Infected Patients, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.38, issue.4, pp.432-438, 2005. ,
DOI : 10.1097/01.qai.0000147524.19122.fd